Kaiser Foundation   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: San Francisco CA United States (1991)

Organization Overview

First Clinical Trial
1991
NCT00000492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Center for Health Research, Kaiser Foundation Hospitals | Kaiser Foundation Research Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Heart Diseases (Phase 3)

Hemorrhage (Phase 3)

Hypertension (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Periodontitis (Phase 2)

Postoperative Hemorrhage (Phase 3)

Vascular Diseases (Phase 2)

Ventricular Fibrillation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 8